Real Polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multi-center, randomized, prospective trial
Cardiovascular Therapeutics, 05/29/2012
Chen SL et al. – The Excel stent was statistically superior to the Dual DES in terms of restenosis, late loss and target vessel revascularization (TVR) for long lesions.



